|Subject||KIST Hongneung TRAIN Program Initiative Co-hosts Bio/Medical Start-up Symposium (2019.06.25)|
KIST Hongneung TRAIN Program Initiative Co-hosts Bio/Medical Start-up Symposium
On June 24 at the Korea Institute of Science and Technology (KIST)’s headquarters in Seoul, the KIST Hongneung TRAIN (Translation & Industrialization) Program Initiative collaborated with Seoul Bio Hub in hosting the Bio/Medical Start-up Ecosystem Activation Symposium.
The KIST Hongneung TRAIN Program Initiative organizes and promotes translational research cooperation and technology commercialization among research institutions and hospitals, whereas Seoul Bio Hub serves as the Seoul Metropolitan Government’s bio/medical startup support network.
The symposium represents a big step for bio/medical startup activation, since KIST retains original technologies and has a great deal of experience in translational research cooperation with hospitals.
Presentations were given by top-level bio/medical experts (both Korean and non-), leading to active discussions with other participants.
The symposium opened with Jay Kim, associate professor at Boston University’s Questrom School of Business, giving the presentation “How Science becomes Business,” emphasizing the necessity for scientists, engineers, and entrepreneurs to work together in creating a national start-up ecosystem. Next, Curtis Sprouse, president of the Institute for Biomedical Entrepreneurship, analyzed the difficulties of technology commercialization and the creation of new start-ups, then followed up by offering practical solutions. Lee Sang-Heon, professor at Korea University College of Medicine, next gave an overview of KU-SPARK, his university’s technology commercialization mentoring program. Finally, Muk Hyunsang, CEO of the Korea Drug Development Fund, gave a presentation titled “Drug Development: a View from the Exit” to generate ideas for training scientists who specialize in the initial stages of drug research.
Dr. Choi Kuiwon, head of the KIST Hongneung TRAIN Program Initiative, said, “The notion of a bio-cluster in Seoul, a city well-equipped to activate Korea’s bio/medical start-up ecosystem, is of great national importance, and today’s symposium brings us one step closer to achieving that goal.”
|Previous||KIST Signs MoU with Kolmar Korea (2019.06.28)|
|Next||Dr. Lee Minah Receives Wiley Young Researcher Award (2019.05.23)|